Overall, Lady Hallett made five recommendations, including reforming the Vaccine Damage Payment Scheme; giving regulatory bodies access to healthcare records for safety monitoring for new vaccines and therapeutics; establishing a “pharmaceutical expert advisory panel” to ensure the UK is well placed to develop, procure and manufacture vaccines and new treatments, and producing targeted vaccine strategies and better monitoring of vaccine uptake and delivery.
